Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

June 24 (Bloomberg) -- Croda International Plc, the world’s second-largest supplier of cosmetic ingredients, cut its profit forecast amid a strengthening pound and subdued demand in Europe. The shares fell the most in almost three years.

Pretax profit for the year is expected to dip below the level of 2013, the Snaith, England-based company said today. Weaker sales of industrial chemicals and a “slightly less favorable” product mix in consumer care led margins to deteriorate in the second quarter, it said.

The dip in performance will heap pressure on Chief Executive Officer Steve Foots to reignite Croda’s growth after years of expansion and peer-group leading profitability. The company is suffering from a bigger-than-expected burden tied to currencies, while a slowdown in European markets is hampering sales of mid-priced ingredients for personal care and household products.

“Whilst the escalation of currency headwinds should come as no surprise, it is disappointing to downgrade forecasts again,” said James Tetley, an analyst at N+1 Singer. “It is clear that stubbornly subdued conditions in Europe are a factor.”

The stock fell as much as 9.5 percent, the biggest intraday decline since August 2011. The shares were down 8.2 percent at 2,208 pence as of 9:32 a.m. in London, taking the drop to 10 percent this year and giving the company a market value of 3 billion pounds ($5.1 billion).

Croda predicted second-quarter pretax profit will be 8 percent lower than in the first three months of the year, instead of holding steady as previously forecast.

Mid-Price Competition

“Costs are very tightly under control, it’s about sales being softer in weak markets,” Finance Director Sean Christie said on a call with analysts.

The U.K. company, which competes with No. 1 cosmetic-ingredient supplier BASF SE, said it remains confident in the long-term strategy of the group and medium-term targets are unchanged. Foots is expanding operations in Asia and other emerging markets to offset weakened European and U.S. demand.

The pound has climbed about 1.5 percent against the dollar this month, and its strength is hurting Croda’s personal-care division, which exports from Europe to the U.S., competing with local companies whose manufacturing costs are in dollars. That’s affected mid-price products, where competition is tougher, Christie said. Croda’s U.S. competitors include Ashland Inc.

“The key for us is to put a lot of effort into Asia and we’re scoring some goals there,” Christie said. While sales growth can be “frustratingly slow” at times, the quality of the orders is high, he added.

To contact the reporter on this story: Andrew Noel in London at

To contact the editors responsible for this story: Simon Thiel at Kim McLaughlin, Robert Valpuesta

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.